| Literature DB >> 21445648 |
Vidar Søyseth1, Helle Laier Johnsen, Merete Drevvatne Bugge, Johny Kongerud.
Abstract
PURPOSE: We have investigated the association between respiratory symptoms and dust exposure among employees in 18 Norwegian smelters using a longitudinal design.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21445648 PMCID: PMC3249535 DOI: 10.1007/s00420-011-0631-x
Source DB: PubMed Journal: Int Arch Occup Environ Health ISSN: 0340-0131 Impact factor: 3.015
The prevalence (% in parentheses) of each symptom by symptom score
| Symptom score | Dyspnéa | Wheezing | Cough without cold | Cough >3 months last year | Phlegm when coughing |
|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 |
| 1 | 91 (13.7) | 47 (8.3) | 151 (20.2) | 1 (0.4) | 120 (19.2) |
| 2 | 167 (25.2) | 136 (24.0) | 177 (23.7) | 30 (11.7) | 130 (20.8) |
| 3 | 153 (23.1) | 145 (25.6) | 162 (21.7) | 54 (21.1) | 140 (22.4) |
| 4 | 149 (22.5) | 136 (24.0) | 155 (20.7) | 69 (26.9) | 131 (21.0) |
| 5 | 103 (15.5) | 103 (18.2) | 103 (13.8) | 103 (40.1) | 103 (16.5) |
| Total | 663 (100.0) | 567 (100.0) | 748 (100.0) | 257 (100.0) | 624 (100.0) |
The prevalence of respiratory symptoms during the follow-up
| Examination no. | ||||||
|---|---|---|---|---|---|---|
| Symptom, | 1 | 2 | 3 | 4 | 5 | 6 |
| Dyspnoea | 708 (23.0) | 605 (21.4) | 475 (19.3) | 398 (19.3) | 301 (18.2) | 151 (16.8) |
| Unknown | 47 (1.5) | 74 (2.6) | 76 (3.1) | 69 (3.3) | 15 (0.9) | 4 (0.4) |
| Wheezing | 598 (19.4) | 500 (17.7) | 443 (18.0) | 341 (16.5) | 273 (16.5) | 142 (15.8) |
| Unknown | 55 (1.8) | 76 (2.7) | 76 (3.1) | 69 (3.3) | 15 (0.9) | 4 (0.4) |
| Cough without a cold | 772 (25.0) | 655 (23.2) | 488 (19.9) | 422 (20.4) | 308 (18.6) | 158 (17.6) |
| Unknown | 76 (2.5) | 101 (3.6) | 101 (4.1) | 82 (4.0) | 26 (1.6) | 8 (0.9) |
| Cough >3 months last year | 267 (8.7) | 271 (9.6) | 224 (9.1) | 181 (8.8) | 137 (8.3) | 66 (7.3) |
| Unknown | 82 (2.7) | 106 (3.8) | 103 (4.2) | 85 (4.1) | 29 (1.8) | 8 (0.9) |
| Phlegm when coughing | 648 (21.0) | 566 (20.0) | 484 (19.7) | 388 (18.8) | 297 (18.0) | 168 (18.7) |
| Unknown | 139 (4.5) | 144 (5.1) | 126 (5.1) | 97 (4.7) | 40 (2.4) | 13 (1.5) |
| Dropouts | ||||||
| N | 149 | 158 | 192 | 80 | 5 | 0 |
| Symptom score, mean | 1.24 | 1.16 | 1.04 | 0.98 | 0.95 | 0.90 |
Range of dust exposure (geometric mean, mg/m3) in each tertile by production
| 1 tertile | 2 tertile | 3 tertile | |
|---|---|---|---|
| FeSi, Si-metal | 0–1.0 | 1.1–3.1 | 3.2–12.6 |
| FeMn, SiMn, FeCr | 0–0.7 | 0.8–1.8 | 1.9–9.9 |
| SiC | 0–0.7 | 0.8–1.9 | 2.0–11.3 |
FeSi, Si-metal ferrosilicon alloys, silicon metal, FeMn ferromanganese, SiMn silicon manganese, FeCr ferrochromium, SiC silicon carbide
Mean symptom score and the corresponding variance (in parentheses) during follow-up by relevant covariates
| Covariate | Follow-up no. | |||||
|---|---|---|---|---|---|---|
| Baseline | 1 | 2 | 3 | 4 | 5 | |
| Gender | ||||||
| Male | 1.02 (2.13) | 0.97 (2.12) | 0.92 (2.01) | 0.89 (2.02) | 0.83 (1.94) | 0.78 (1.86) |
| Female | 0.71 (1.38) | 0.66 (1.55) | 0.62 (1.51) | 0.57 (1.28) | 0.52 (1.30) | 0.61 (1.71) |
| Age (years) | ||||||
| 20–34 | 0.87 (1.75) | 0.84 (1.87) | 0.75 (1.66) | 0.70 (1.51) | 0.65 (1.38) | 0.45 (1.20) |
| 35–44 | 1.05 (2.21) | 1.00 (2.22) | 0.93 (2.06) | 0.92 (2.23) | 0.74 (1.77) | 0.77 (1.86) |
| 45+ | 1.05 (2.23) | 0.96 (2.09) | 0.94 (2.06) | 0.87 (1.92) | 0.89 (2.11) | 0.84 (1.97) |
| Smoking | ||||||
| Never smoker | 0.60 (1.31) | 0.49 (1.08) | 0.49 (1.10) | 0.46 (1.20) | 0.48 (1.24) | 0.48 (1.25) |
| Former smoker | 0.73 (1.58) | 0.66 (1.49) | 0.59 (1.39) | 0.56 (1.36) | 0.56 (1.27) | 0.60 (1.51) |
| Current (cig/day) | ||||||
| 1–9 | 1.04 (2.18) | 1.05 (2.27) | 0.99 (2.10) | 0.98 (2.02) | 0.92 (2.03) | 0.78 (1.68) |
| 10–19 | 1.49 (2.48) | 1.46 (2.74) | 1.45 (2.61) | 1.44 (2.63) | 1.32 (2.71) | 1.31 (2.75) |
| 20+ | 2.22 (3.36) | 2.31 (2.57) | 1.81 (3.08) | 1.65 (2.70) | 1.72 (2.94) | 1.55 (2.76) |
| Job categories | ||||||
| Unexposed | 0.62 (1.26) | 0.65 (1.53) | 0.65 (1.50) | 0.62 (1.52) | 0.61 (1.51) | 0.87 (2.11) |
| Non-line operators | 0.96 (2.04) | 0.93 (2.17) | 0.85 (1.90) | 0.81 (1.90) | 0.80 (2.06) | 0.77 (1.93) |
| Line operators | 1.10 (2.23) | 1.02 (2.11) | 0.99 (2.14) | 0.95 (2.09) | 0.84 (1.76) | 0.72 (1.66) |
| Dropout | ||||||
| Yes | 1.15 (2.27) | 1.06 (2.25) | 0.95 (2.01) | 1.12 (2.40) | 1.80 (3.20) | n.a. |
| No | 0.95 (2.00) | 0.91 (2.03) | 0.88 (1.96) | 0.84 (1.93) | 0.79 (1.88) | 0.77 (1.93) |
| Dust exposure* (tertiles) | ||||||
| First | 0.82 (1.72) | 0.78 (1.80) | 0.80 (1.79) | 0.74 (1.73) | 0.77 (1.93) | 0.85 (2.03) |
| Second | 1.06 (2.24) | 1.03 (2.12) | 0.94 (2.04) | 0.98 (2.18) | 0.82 (1.77) | 0.73 (1.68) |
| Third | 1.05 (2.13) | 0.99 (2.24) | 0.91 (2.04) | 0.84 (1.91) | 0.80 (1.94) | 0.69 (1.80) |
| Previous exposure | ||||||
| Yes | 1.10 (2.26) | 1.05 (2.28) | 0.96 (2.11) | 0.93 (2.13) | 0.86 (2.01) | 0.79 (1.91) |
| No | 0.72 (1.51) | 0.66 (1.49) | 0.72 (1.57) | 0.65 (1.44) | 0.62 (1.49) | 0.66 (1.61) |
n.a not available. * See Table 2
Symptom-score ratio (SSR) with 95% confidence intervals (95% CI) at baseline and during the follow-up by relevant covariates using multivariate Poisson regression
| Longitudinal analyses (follow-up) | ||||||
|---|---|---|---|---|---|---|
| Cross-sectional (baseline) | Dropouts | Non-dropouts | ||||
| SSR | 95% CI | SSR | 95% CI | SSR | 95% CI | |
| Follow-up time (years) | – | – | 0.95 | 0.88–1.01 | 0.95 | 0.93–0.96 |
| Job categories | ||||||
| Unexposed | 1 | 1 | 1 | |||
| Non-line operators | 1.35 | 1.10–1.66 | 1.39 | 1.09–1.77 | 1.12 | 1.00–1.26 |
| Line operators | 1.45 | 1.18–1.78 | 1.61 | 1.27–2.05 | 1.13 | 1.01–1.27 |
| Gender | ||||||
| Male | 1 | 1 | 1 | |||
| Female | 0.82 | 0.67–1.00 | 0.91 | 0.73–1.14 | 0.73 | 0.65–0.82 |
| Familial asthma: yes versus no | 1.39 | 1.24–1.55 | 1.42 | 1.23–1.65 | 1.33 | 1.24–1.42 |
| DD asthma: yes versus no | 1.76 | 1.52–2.03 | 1.54 | 1.27–1.88 | 1.58 | 1.44–1.73 |
| Allergy: yes versus no | 1.39 | 1.23–1.57 | 1.57 | 1.35–1.83 | 1.28 | 1.19–1.38 |
| Age (years) | ||||||
| 20–34 | 1 | 1 | 1 | |||
| 35–44 | 1.17 | 1.03–1.33 | 1.34 | 1.13–1.60 | 1.16 | 1.07–1.26 |
| 45+ | 1.31 | 1.14–1.50 | 1.57 | 1.31–1.87 | 1.26 | 1.16–1.37 |
| Smoking | ||||||
| Never smoker | 1 | 1 | 1 | |||
| Former smoker | 1.09 | 0.91–1.29 | 1.13 | 0.88–1.45 | 1.12 | 1.02–1.24 |
| Current (cig/day) | ||||||
| 1–9 | 1.61 | 1.38–1.89 | 1.90 | 1.53–2.35 | 1.81 | 1.65–1.99 |
| 10–19 | 2.23 | 1.94–2.57 | 2.93 | 2.43–3.54 | 2.55 | 2.34–2.78 |
| 20+ | 3.27 | 2.63–4.07 | 3.94 | 2.98–5.21 | 3.46 | 3.04–3.92 |
| Previous exposure | ||||||
| No | 1 | 1 | 1 | |||
| Yes | 1.22 | 1.06–1.42 | 1.14 | 0.94–1.38 | 1.21 | 1.11–1.33 |
DD asthma doctor diagnosed asthma. All variables are mutually adjusted
Symptom-score ratio at baseline and during the follow-up in dropouts and non-dropouts by tertiles of dust exposure using the same covariates as in Table 5
| Tertiles* of dust exposure | Baseline | Dropouts | Non-dropouts | |||
|---|---|---|---|---|---|---|
| SSR | 95% CI | SSR | 95% CI | SSR | 95% CI | |
| First | 1 | 1 | 1 | |||
| Second | 1.12 | 0.98–1.28 | 1.28 | 1.05–1.55 | 1.04 | 0.96–1.12 |
| Third | 1.11 | 0.97–1.28 | 1.37 | 1.13–1.66 | 1.04 | 0.95–1.14 |
* See Table 2